TSX:BHC (Bausch Health Companies Inc.)

About BHC

Bausch Health Companies Inc. is a global company that develops manufactures and markets a range of pharmaceutical medical device and over-the-counter products primarily in the therapeutic areas of eye health gastroenterology and dermatology. We are delivering on our commitments as we build an innovative company dedicated to advancing global health. Our approximately 22000 employees are united around our mission of improving peoples lives with our health care products and we manufacture and market health care products directly or indirectly in approximately 100 countries. Five pillars or guiding principles represent the foundation on which we are realizing our mission as an organization: People Quality Health Care Outcomes Customer Focus Innovation and Efficiency.
  • Bausch Health Companies Inc. (TSX: BHC) Latest News

    The Motley Fool
    Investing

    The CFO’s Buying – Are You?

    An academic study indicates there's one insider who's actions mean more than the others.

    Read more »

    The Motley Fool
    Investing

    Canadian Stocks Going for a Memorial Day Run

    Closed U.S. markets haven't stopped these three names from surging higher.

    Read more »

    The Motley Fool
    Investing

    Valeant Pharmaceuticals Shares Jump on Rumoured Deal

    This company is going to pull off a massive deal one way or the other.

    Read more »

    The Motley Fool
    Investing

    Royal Bank of Canada Powers the TSX Higher

    Gold, oil down, Canada's market up. Huh?

    Read more »

    The Motley Fool
    Investing

    Valeant, Capstone Higher But For Opposite Reasons

    One company is a serial acquirer that faces a busted deal. The other just transformed the company in one fell…

    Read more »

    The Motley Fool
    Investing

    Resources Out, Defensives In

    The market speaks as to which Canadian large-caps are considered "defensive".

    Read more »

    The Motley Fool
    Investing

    Valeant Wins Obagi

    Ring up another "win" for Valeant!

    Read more »

    The Motley Fool
    Investing

    Rail Stocks Helped Pull the S&P/TSX Composite Higher in the First Quarter

    Solid returns from several marquee names resulted in a positive first quarter for the S&P/TSX Composite.

    Read more »

    The Motley Fool
    Investing

    Serialously – Another Acquisition for Valeant

    This serial acquirer is sticking with its strategy. The company's sizeable debt burden makes this a risky proposition.

    Read more »

    The Motley Fool
    Investing

    Smoke Today, Fire Tomorrow?

    One of the things that can ruin a company is financial risk. Valeant Pharmaceuticals is loaded with it and nobody…

    Read more »